Logos Global Management »

Atyr Pharma shares owned by Logos Global Management

Quarter-by-quarter ownership of Atyr Pharma (LIFE) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by Logos Global Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.2M 5.9M 1.41

More positions owned by Logos Global Management

Cytokinetics Com New (CYTK)
Apellis Pharmaceuticals (APLS)
Sarepta Therapeutics Call Option (SRPT)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Olema Pharmaceuticals (OLMA)
Immunovant (IMVT)
Structure Therapeutics Sponsored Ads (GPCR)
Rocket Pharmaceuticals (RCKT)
Rayzebio
Ambrx Biopharma
Karuna Therapeutics Ord
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Morphosys Sponsored Ads Call Option (MOR)

View all positions for Logos Global Management

Top funds holding Atyr Pharma

Federated Investors
Logos Global Management
Alyeska Investment Group
Vanguard Group
Citadel Advisors
Checkpoint Capital
Tang Capital Management
GSA Capital Partners
Dimensional Fund Advisors
Bank of America Corporation
Two Sigma Advisers
Goldman Sachs Group
Millennium Management
Squarepoint Ops
Royal Bank of Canada

View all funds holding Atyr Pharma